Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -221.72% is 367% below its 5-year average of -47.50%, around the middle of its 5-year range (-346.08%–0.00%).
5.48% above its 12-month average of -234.57%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -127.29%.
OPERATING MARGIN
-221.72%
OPERATING MARGIN AVG TTM
-234.57%
OPERATING MARGIN AVG 3Y
-99.70%
OPERATING MARGIN AVG 5Y
-47.50%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+5.48%
CURRENT VS 3Y AVG
-122.38%
CURRENT VS 5Y AVG
-366.75%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 384 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Alpha Cognition Inc
Market Cap
$142.11M
Operating Margin
-221.72%
TTM Avg
-234.57%
3Y Avg
-99.70%
5Y Avg
-47.50%
Market Cap
$142.49M
Operating Margin
-111.00%
TTM Avg
-151.19%
3Y Avg
-184.89%
5Y Avg
-203.40%
Market Cap
$134.74M
Operating Margin
-7.85%
TTM Avg
-2.10%
3Y Avg
-0.51%
5Y Avg
4.29%
Market Cap
$149.51M
Operating Margin
-54.46%
TTM Avg
-76.53%
3Y Avg
-68.82%
5Y Avg
-55.26%
Market Cap
$152.16M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-8182.07%
Market Cap
$152.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$153.84M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-91.83%
Market Cap
$129.14M
Operating Margin
-27450.00%
TTM Avg
-16372.79%
3Y Avg
-10624.45%
5Y Avg
-7949.52%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $142.11M | -221.72% | -234.57% | -99.70% | -47.50% |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | -111.00% | -151.19% | -184.89% | -203.40% |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | -7.85% | -2.10% | -0.51% | 4.29% |
| Codexis, Inc. (CDXS)vs › | $149.51M | -54.46% | -76.53% | -68.82% | -55.26% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | 0.00% | 0.00% | 0.00% | -8182.07% |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | 0.00% | 0.00% | 0.00% | -91.83% |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | -27450.00% | -16372.79% | -10624.45% | -7949.52% |
| Cibus, Inc. (CBUS)vs › | $128.24M | -1853.92% | -1829.87% | -8864.53% | -5959.13% |
Gross Margin
81.3%
Operating Margin
-221.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -127.29% |
| 2026-03-31 | -229.11% |
| 2025-12-31 | -283.75% |
| 2025-09-30 | -186.63% |
| 2025-06-30 | -346.08% |
| 2025-03-31 | -123.28% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2021-01-31 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 0.00% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
